Evidence provided by a study performed in psoriasis patients suggests that the use of TNF-α inhibitors leads to lower concentrations of the vitamin D [18], but another study focused only on Etanercept administration did not prove any link between lower levels of vitamin D and the use of the biological drug [15]. This evidence concerns the gene TNF and psoriasis.